Sponsor Pipeline

Lantheus Medical Imaging Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06074510 PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer Prostate Cancer Active, Not Recruiting
Phase 1/2
NCT06298916 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer Metastatic Sarcoma Recruiting
NCT07357519 Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy) Relapsed / Refractory Osteosarcoma Recruiting
Disease Areas
Sarcoma (2) Prostate Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Gastric Cancer (1) Esophageal Cancer (1)
Get alerts when Lantheus Medical Imaging's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free